Orchestra BioMed Holdings, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Orchestra BioMed Holdings, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2020 to Q1 2024.
  • Orchestra BioMed Holdings, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $18K.
  • Orchestra BioMed Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $46.2M, a 55.2% decline from 2022.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $18K* -$56.8M Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $56.8M +$32.1M +129% Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $24.8M Mar 31, 2022 10-Q 2023-05-12
Q3 2020 $162M Sep 30, 2020 10-Q/A 2022-03-31
Q2 2020 $194K Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.